Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 15:10:1223660.
doi: 10.3389/fcvm.2023.1223660. eCollection 2023.

Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals

Irma Bisceglia  1 , Maria Laura Canale  2 , Nicola Silvestris  3 , Giuseppina Gallucci  4 , Andrea Camerini  5 , Alessandro Inno  6 , Massimiliano Camilli  7 , Fabio Maria Turazza  8 , Giulia Russo  9 , Andrea Paccone  10 , Raffaella Mistrulli  11 , Leonardo De Luca  12 , Stefania Angela Di Fusco  13 , Luigi Tarantini  14 , Fabiana Lucà  15 , Stefano Oliva  16 , Antonella Moreo  17 , Nicola Maurea  10 , Vincenzo Quagliariello  10 , Giuseppina Rosaria Ricciardi  18 , Chiara Lestuzzi  19 , Damiana Fiscella  20 , Iris Parrini  21 , Vito Racanelli  22 , Antonio Russo  23 , Lorena Incorvaia  23 , Fabio Calabrò  24 , Giuseppe Curigliano  25 , Saverio Cinieri  26 , Michele Massimo Gulizia  20 , Domenico Gabrielli  12   12 , Fabrizio Oliva  27 , Furio Colivicchi  13
Affiliations
Review

Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals

Irma Bisceglia et al. Front Cardiovasc Med. .

Erratum in

  • Corrigendum: Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals.
    Bisceglia I, Canale ML, Silvestris N, Gallucci G, Camerini A, Inno A, Camilli M, Turazza FM, Russo G, Paccone A, Mistrulli R, De Luca L, Di Fusco SA, Tarantini L, Lucà F, Oliva S, Moreo A, Maurea N, Quagliariello V, Ricciardi GR, Lestuzzi C, Fiscella D, Parrini I, Racanelli V, Russo A, Incorvaia L, Calabrò F, Curigliano G, Cinieri S, Gulizia MM, Gabrielli D, Oliva F, Colivicchi F. Bisceglia I, et al. Front Cardiovasc Med. 2023 Oct 25;10:1309921. doi: 10.3389/fcvm.2023.1309921. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37953759 Free PMC article.

Abstract

In cancer, a patient is considered a survivor from the time of initial diagnosis until the end of life. With improvements in early diagnosis and treatment, the number of cancer survivors (CS) has grown considerably and includes: (1) Patients cured and free from cancer who may be at risk of late-onset cancer therapy-related cardiovascular toxicity (CTR-CVT); (2) Patients with long-term control of not-curable cancers in whom CTR-CVT may need to be addressed. This paper highlights the importance of the cancer care continuum, of a patient-centered approach and of a prevention-oriented policy. The ultimate goal is a personalized care of CS, achievable only through a multidisciplinary-guided survivorship care plan, one that replaces the fragmented management of current healthcare systems. Collaboration between oncologists and cardiologists is the pillar of a framework in which primary care providers and other specialists must be engaged and in which familial, social and environmental factors are also taken into account.

Keywords: cancer survivors (CSs); cancer therapy-related cardiovascular toxicities (CTR-CVT); cardiovascular disease (CVD); cardiovascular risk factors (CVRF); reverse cardio-oncology; survivorship care.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Life's essentials 8 in preventive cardio-oncology: the ABCDEF approach with behavioral components, ideal parameters and psychological/sociological issues (in green) working as interactive gears [modified from brown SA (57) and Lloyd-Jones DM et al. (58, 59)]. Non-HDL, non high density lipoprotein cholesterol; FBG, fasting blood glucose; HbA1c, hemoglobin A1c; CO, cardio-oncology.
Figure 2
Figure 2
Areas to be addressed in survivorship care plans (modified from Vaz-luis et al. 125).
Figure 3
Figure 3
A comprehensive multidisciplinary care plan supporting every cancer survivor. Cardio-Oncologists and Onco-Hematologists guide the pre-treatment red phase while PCP, PCG and Pre-hab have a helping role. Treatment blue phase is more challenging, therefore Cardio- Oncologists, Onco-Hematologists, PCP, PCG, and Rehabilitation team all together lead the way in a close collaboration. PCP, PCG and geriatricians are in charge in the long post-treatment green phase getting advices from Cardio-Oncologists, Onco-Hematologists, and Post-hab team. A support team is always backing-up. Patients are the core of the survivorship plan and they become super-powered during the journey (Patient Empowerment). Telemedicine will facilitate patient-healthcare providers' interactions in each phase. PCP, Primary Care Provider; PCG, primary CareGivers.
See this image and copyright information in PMC

References

    1. NCI Dictionary of Cancer Terms: Cancer Survivor. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivor (Accessed September 1st, 2022).
    1. Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. (2022) 72(5):409–36. 10.3322/caac.21731 - DOI - PubMed
    1. Europe’s beating Cancer Plan. Communication from the Commission to the European Parliament and the Council. (2021).
    1. Suh E, Stratton KL, Leisenring WM, Nathan PC, Ford JS, Freyer DR, et al. Late mortality and chronic health conditions in long- term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the childhood cancer survivor study. Lancet Oncol. (2020) 21(3):421–35. 10.1016/S1470-2045(19)30800-9 - DOI - PMC - PubMed
    1. Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev. (2016) 25:1029–36. 10.1158/1055-9965.EPI-16-0133 - DOI - PMC - PubMed

LinkOut - more resources